Abiopharma

🔍 Shopify Strategic Holdings 3 LLC (Executive)

Company: Klaviyo, Inc. (KVYO)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Sold 344,383 shares of Warrants to Purchase Series B Common Stock (Right to Buy) at $0.01 per share (Derivative)
  Date: 2026-08-31 | Code: X | Expires: 2032-07-28 | equity_swap_involved: false | shares_owned_after: 1,377,529.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 344,383 shares of Series B Common Stock (Derivative)
  Date: 2026-08-31 | Code: X | equity_swap_involved: false | shares_owned_after: 17,317,491.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F2

Footnotes:

• F1: 25% of the shares subject to the warrants vested on July 28, 2022, and the remaining shares vest quarterly in equal amounts through July 28, 2027. Notwithstanding the foregoing, in connection with the Issuer's initial public offering ("IPO"), 25% of the total number of shares subject to the warrants vested immediately prior to the completion of the IPO.
• F2: Reflects securities held directly by Shopify Strategic Holdings 3 LLC, a wholly-owned subsidiary of Shopify Inc. ("Shopify"). Shopify is an indirect beneficial owner and disclaims beneficial ownership except to the extent of its pecuniary interest therein.
• F3: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.